Literature DB >> 14695396

Prostate cancer localization with endorectal MR imaging and MR spectroscopic imaging: effect of clinical data on reader accuracy.

Rajpal Dhingsa1, Aliya Qayyum, Fergus V Coakley, Ying Lu, Kirk D Jones, Mark G Swanson, Peter R Carroll, Hedvig Hricak, John Kurhanewicz.   

Abstract

PURPOSE: To determine the effect of digital rectal examination findings, sextant biopsy results, and prostate-specific antigen (PSA) levels on reader accuracy in the localization of prostate cancer with endorectal magnetic resonance (MR) imaging and MR spectroscopic imaging.
MATERIALS AND METHODS: This was a retrospective study of 37 patients (mean age, 57 years) with biopsy-proved prostate cancer. Transverse T1-weighted, transverse high-spatial-resolution, and coronal T2-weighted MR images and MR spectroscopic images were obtained. Two independent readers, unaware of clinical data, recorded the size and location of suspicious peripheral zone tumor nodules on a standardized diagram of the prostate. Readers also recorded their degree of diagnostic confidence for each nodule on a five-point scale. Both readers repeated this interpretation with knowledge of rectal examination findings, sextant biopsy results, and PSA level. Step-section histopathologic findings were the reference standard. Logistic regression analysis with generalized estimating equations was used to correlate tumor detection with clinical data, and alternative free-response receiver operating characteristic (AFROC) curve analysis was used to examine the overall effect of clinical data on all positive results.
RESULTS: Fifty-one peripheral zone tumor nodules were identified at histopathologic evaluation. Logistic regression analysis showed awareness of clinical data significantly improved tumor detection rate (P <.02) from 15 to 19 nodules for reader 1 and from 13 to 19 nodules for reader 2 (27%-37% overall) by using both size and location criteria. AFROC analysis showed no significant change in overall reader performance because there was an associated increase in the number of false-positive findings with awareness of clinical data, from 11 to 21 for reader 1 and from 16 to 25 for reader 2.
CONCLUSION: Awareness of clinical data significantly improves reader detection of prostate cancer nodules with endorectal MR imaging and MR spectroscopic imaging, but there is no overall change in reader accuracy, because of an associated increase in false-positive findings. A stricter definition of a true-positive result is associated with reduced sensitivity for prostate cancer nodule detection. Copyright RSNA, 2004

Entities:  

Mesh:

Year:  2004        PMID: 14695396     DOI: 10.1148/radiol.2301021562

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  21 in total

1.  Is 11C-choline the most appropriate tracer for prostate cancer? Against.

Authors:  Klaus Zöphel; Jörg Kotzerke
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-04-02       Impact factor: 9.236

2.  Prostate cancer managed with active surveillance: role of anatomic MR imaging and MR spectroscopic imaging.

Authors:  Vincent Fradet; John Kurhanewicz; Janet E Cowan; Alexander Karl; Fergus V Coakley; Katsuto Shinohara; Peter R Carroll
Journal:  Radiology       Date:  2010-05-26       Impact factor: 11.105

3.  Reproducibility of image interpretation in MRI of the prostate: application of the sextant framework by two different radiologists.

Authors:  Ullrich Mueller-Lisse; Ulrike Mueller-Lisse; Juergen Scheidler; Gerhardt Klein; Maximilian Reiser
Journal:  Eur Radiol       Date:  2005-04-20       Impact factor: 5.315

Review 4.  Prostate MR imaging at high-field strength: evolution or revolution?

Authors:  Olivier Rouvière; Robert P Hartman; Denis Lyonnet
Journal:  Eur Radiol       Date:  2005-09-10       Impact factor: 5.315

Review 5.  Is it time to consider a role for MRI before prostate biopsy?

Authors:  Hashim U Ahmed; Alex Kirkham; Manit Arya; Rowland Illing; Alex Freeman; Clare Allen; Mark Emberton
Journal:  Nat Rev Clin Oncol       Date:  2009-04       Impact factor: 66.675

6.  Effect of diagnostic predictions combined with clinical information on avoiding perceptual errors of computed tomography.

Authors:  Shingo Suzuki; Masatomi Ikusaka; Yoshiyuki Ohira; Masahito Miyahara; Kazutaka Noda; Hideki Kajiwara; Kiyoshi Shikino; Takeshi Kondo
Journal:  Jpn J Radiol       Date:  2013-09-14       Impact factor: 2.374

7.  Prediction of biochemical recurrence following radical prostatectomy in men with prostate cancer by diffusion-weighted magnetic resonance imaging: initial results.

Authors:  Sung Yoon Park; Chan Kyo Kim; Byung Kwan Park; Hyun Moo Lee; Kyung Soo Lee
Journal:  Eur Radiol       Date:  2010-11-03       Impact factor: 5.315

8.  Seminal vesicle invasion in prostate cancer: prediction with combined T2-weighted and diffusion-weighted MR imaging.

Authors:  Jing Ren; Yi Huan; He Wang; YaLi Ge; YingJuan Chang; Hong Yin; LiJun Sun
Journal:  Eur Radiol       Date:  2009-06-10       Impact factor: 5.315

9.  MR-guided transgluteal biopsies with an open low-field system in patients with clinically suspected prostate cancer: technique and preliminary results.

Authors:  Stephan Zangos; Katrin Eichler; Kerstin Engelmann; Mukhtiar Ahmed; Sebastian Dettmer; Christopher Herzog; Wasilios Pegios; A Wetter; Thomas Lehnert; Martin G Mack; Thomas J Vogl
Journal:  Eur Radiol       Date:  2004-09-04       Impact factor: 5.315

Review 10.  Advances in MR spectroscopy of the prostate.

Authors:  John Kurhanewicz; Daniel B Vigneron
Journal:  Magn Reson Imaging Clin N Am       Date:  2008-11       Impact factor: 2.266

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.